Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm

Ron Dagan1, Galia Barkai, Eugene Leibovitz

  • 1Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel. rdagan@bgu.ac.il

Insights

Antibiotic prescribing for children

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial resistance
  • Pharmacology

Background:

  • Community-acquired respiratory infections are a primary reason for antibiotic use in children.
  • Widespread antibiotic use contributes to the emergence of antimicrobial resistance.
  • Differences in resistance promotion potential among antibiotics are often overlooked.

Purpose of the Study:

  • To review antibiotic prescribing trends in young children.
  • To examine the relationship between antibiotic use and *Streptococcus pneumoniae* resistance.
  • To identify antibiotics with the lowest resistance-promotion potential.

Main Methods:

  • Review of antibiotic prescribing patterns in pediatric populations.
  • Analysis of clinical respiratory isolates of *S. pneumoniae*.
  • Evaluation of theoretical considerations and research evidence on antibiotic resistance promotion.

Main Results:

  • Amoxicillin (+/- clavulanate) showed the least resistance-promoting effect against *S. pneumoniae*.
  • Oral cephalosporins and azithromycin exhibited higher resistance-promotion potential.
  • All reviewed antibiotics contribute to the promotion of antimicrobial resistance.

Conclusions:

  • Antibiotic choice significantly impacts resistance development in *S. pneumoniae*.
  • Amoxicillin is a preferred agent for reducing resistance promotion in pediatric respiratory infections.
  • Strategies to reduce antibiotic resistance must consider differential resistance promotion potentials.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Antibiotic Selection00:57

Antibiotic Selection

Overview